Johnson & Johnson, Becton Dickinson Highlighted for 55-Year Dividend Growth Streaks

An analysis by Investing.com has highlighted two healthcare sector stalwarts, Johnson & Johnson (NYSE: JNJ) and Becton, Dickinson and Company (NYSE: BDX), for their remarkable consistency in shareholder returns. Both companies have successfully increased their dividends for 55 consecutive years, earning them the title of "Dividend Kings."

Johnson & Johnson: Momentum and Profitability

Johnson & Johnson, a blue-chip healthcare conglomerate, has combined its dividend track record with significant stock momentum, posting a +53% return over the past year, according to the source's data. The company's revenue has grown consistently, reaching $94.19 billion in the last fiscal year.

The analysis points to J&J's strong profitability metrics, including a return on equity (ROE) of 25.7% and a net income margin of 21.5%. However, it also suggests that the stock may be fully valued, with an estimated fair value upside of just 2.1% from its current price.

Becton Dickinson: Revenue Growth and Value

Medical technology firm Becton Dickinson was noted for its robust top-line growth. The company's revenue increased by +15.5%, a figure reported as the strongest among the Dividend Kings screened in the analysis.

Ad

Despite a one-year stock return of +25.4%, the analysis identified a potential fair value upside of 25.6% for BDX. The company offers a dividend yield of 2.5%, slightly higher than J&J's 2.1%. In contrast to J&J, BDX operates on thinner margins, with an ROE of 6.7% and a net income margin of 5.1%, reflecting a business model more reliant on volume.

Contrasting Investment Profiles

The two companies present different profiles for investors, based on the provided metrics. Johnson & Johnson is characterized by its large market capitalization ($621.75 billion), high profitability, and strong recent stock performance that appears largely priced in by the market.

Becton Dickinson, with a market cap of $46.92 billion, is presented as a company with a stronger revenue growth trajectory and more significant potential for stock price appreciation, according to the fair value estimate. This combination of consistent dividend growth and differing financial characteristics offers a complementary view of two of the market's most durable dividend payers.